Delta Pharma is a finished-dose manufacturer based in Pakistan. It appears in 371 regulatory filings across 11 regulators, without an active US DMF or CEP on file. Its filings concentrate with EDA (EG), INFARMED (PT) and NMRC (NA). Its GMP standing is certified by NAFDAC (NG), EDA (EG) and DRAP (PK), among 4 authorities. Its most recent recorded inspection, by US FDA, closed on 15 August 2024 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Quebec, United Arab Emirates | Not on file |
| Canada, Canada | 3003264747 |
| nowshera, Pakistan | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| EDA (EG) | 245 | 1 |
| INFARMED (PT) | 101 | None |
| NMRC (NA) | 5 | None |
| DIGEMAPS (DO) | 4 | None |
| NAFDAC (NG) | 4 | 1 |
| EEC_EAEU | 4 | None |
| DRAP (PK) | None | 1 |
| US FDA | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2025 | $514K | Not reported | Not reported |
| 2022 | $130.0B | Not reported | Not reported |
| 2021 | $160.0B | Not reported | Not reported |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Delta Pharma comes back tiered against every other supplier able to file there.
Start for free